Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Hepatitis C RNA in 15 Minutes
Point of care testing Screening and monitoring Infectious Disease

Hepatitis C RNA in 15 Minutes?

A rapid point-of-care PCR test aims to close the gap between screening and diagnosis

01/08/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Scorecard: Hepatitis C RNA in 15 Minutes?

At a Glance

CategoryDetail
ConditionHepatitis C Virus (HCV) Infection
Key MechanismsRapid detection of HCV RNA using the DASH® Rapid PCR System.
Target PopulationIndividuals undergoing HCV screening and diagnosis.
Care SettingCommunity clinics, outreach programs, and settings with limited access to centralized laboratories.

Key Highlights

  • DASH® HCV test delivers results in approximately 15 minutes.
  • Qualitative RT-qPCR assay with a detection limit of 200 IU/mL.
  • 100% positive and negative agreement with established laboratory-based RNA assays.
  • No cross-reactivity with other bloodborne pathogens.
  • Potential to streamline HCV diagnostic pathway and reduce patient loss to follow-up.

Guideline-Based Recommendations

Diagnosis

  • Utilize rapid molecular POC testing for confirmation of active HCV infection.

Management

  • Consider the DASH® HCV test for immediate diagnosis in clinical settings.

Monitoring & Follow-up

  • Further studies needed to assess its use for treatment monitoring.

Risks

  • Analytical sensitivity is lower than high-throughput laboratory tests.

Patient & Prescribing Data

Patients suspected of HCV infection requiring rapid confirmation.

Early confirmation may support timely clinical decision-making.

Clinical Best Practices

  • Implement rapid POC testing in settings with limited laboratory access.
  • Ensure minimal operator training for effective use of the DASH® system.
  • Monitor for potential limitations in analytical sensitivity.

References

  • The Journal of Infectious Diseases

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

What’s New in Infectious Disease? (December 2021)
Point of care testing
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Resisting Resistance
Point of care testing
Resisting Resistance

October 21, 2016

1 min read

Rapid, affordable tests to spot bacterial infections could reduce antibiotic overprescription in resource-limited settings

HIV/AIDS: A Shifting Epidemic
Point of care testing
HIV/AIDS: A Shifting Epidemic

April 4, 2022

1 min read

HIV diagnoses in heterosexual people in the UK have overtaken those in gay and bisexual men

Career Snapshots with Bamidele Farinre
Point of care testing
Career Snapshots with Bamidele Farinre

April 20, 2022

3 min read

Michael Schubert interviews Bamidele Farinre about her work in mobile laboratory testing

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.